This booklet is for men who are having hormone therapy for prostate cancer, their partners and families. It describes the different types of hormone therapy, how they work and what the treatment involves. It includes information on the possible side effects men may experience and suggests ways to help manage these.


Updated: May 2013 | Due for Review: May 2015

  • Alibhai SMH, Gogov S, Alllibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Critical reviews in Oncology/Hematology 60 (2006) 201-215
  • Beard C, Stason WB, Wang Q, Manola J, Dean-Clower E, Dusek JA, Decristofaro S, Webster A, Rosenthal DS, Benson H. Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer. Cancer. 2010 Aug 27
  • Beck AM, Robinson JW, Carlson LE et al. Sexual intimacy in heterosexual couples after prostate cancer treatment: What we know and what we still need to learn. Urol Oncol. 2008
  • Carlson LE, Bultz BD. Mind-body interventions in oncology. Curr Treat Options Oncol. 2008;9(2-3):127-34
  • Di Lorenzo G, Autorino R, Perdona S et al. Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncology 2005; 6: 972-79
  • Drudge-Coates L. Bone health: the effect of androgen deprivation therapy in prostate cancer patients. International Journal of Urological Nursing 2007; 1(1): 18-26
  • Eastham JA. Bone health in men receiving androgen deprivation therapy for prostate cancer. J Urol 2007; 177:17-24
  • Elkins G, Marcus J, Stearns V et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. Journal of Clinical Oncology. 2008;26(31):5022-6
  • Elliott s, Latini DM, Walker LM et al. Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life. J Sex Med. 2010
  • Foley E, Baillie A, Huxter M, Price M, Sinclair E. Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: a randomized controlled trial. J Consult Clin Psychol. 2010 Feb;78(1):72-9
  • Fradet Y, Egerdie B, Andersen M, et al. Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150 mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose-Response Study. European Urology. 2007;52:106-115
  • Grossmann M, Hamilton E, Gilfillan C, et al. Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. Medical Journal of Australia. 2011; 194(6):301-6
  • Gruca D, Bacher P & Tunn U. Safety and tolerability of intermittent androgen deprivation therapy: A literature review. International Journal of Urology. 2012;19:614-625
  • Haliloglu A, Baltaci S, and Yaman O. Penile Length Changes in Men Treated With Androgen Suppression Plus Radiation Therapy for Local or Locally Advanced Prostate Cancer. The Journal of Urology 2007:77,128-130
  • Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J Cancer Surviv. 2010;4(2):128-39
  • Heidenreich A, Bolla M, Joniau S et al. Guidelines on prostate cancer. European Association of Urology. 2012
    Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 2003; 61(Suppl 2A): 32-38
  • Irani J, Salomon L, Oba R et al. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol. 2010;11:147-154
  • Iversen P, Karup C, van der Meulen E. Hot flushes in prostatic cancer patients during androgen-deprivation therapy with monthly dose of degarelix or leuprolide. Prostate Cancer and Prostatic Diseases. (2011);14:184-190
  • Jamadar RJ, Winters MJ & Maki PM. Cognitive changes associated with ADT: a review of the Literature. Asian Journal of Andrology. 2012;14:232-238
  • Jones JM, Kohli M & Loprinzi CL. Androgen deprivation therapy-associated vasometer symptoms. Asian J androl. 2012;14(2):193-197
  • Karling P, Hammar M, Varenhorst E. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol. 1994 Oct;152(4):1170-3
  • Keogh JWL & MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: A systematic review. Journal of pain and symptom management. 2012;43(1):93-110
  • Lee MS, Kim K-H, Shin B-C et al. Acupuncture for treating hot flushes in men with prostate cancer: a systematic review. Support Care Cancer. 2009;17:763-770
  • Loblaw DA, Virgo KS, Nam R et al. Initial hormonal management of androgen-sensitive Metastatic, recurrent, or progressive prostate cancer - 2006 update of an American Society of Clinical Oncology practice guideline. Journal of Clinical Oncology 2007; 25(12): 1596-1605
  • Mann E, Smith MJ, Hellier J, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncology. 2012;13(3):309-18
  • Medicines and Healthcare products Regulatory Agency. UKPAR Black Cohosh, UK Public Assessment Report, Available at: Accessed September 2012
  • Mohile SG, Mustian K, Bylow K t al. Management of complications of androgen deprivation therapy in the older man. Crit Rev Oncol Hematol. 2009;70(3):235-255
  • Mottet, Prayer-Galetti, Hammerert Pet al. Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer. BJU Int. 2006; 98: 20-27
  • National Institute for Health and Clinical Excellence. 2008. Prostate cancer: diagnosis and treatment
  • National Osteoporosis Society. Osteoporosis: causes, prevention and treatment. 2001. Bath: NOS
  • Nelson CJ, Lee JS, Gamboa MC et al. Cognitive effects of hormone therapy in men with prostate cancer: a review. Cancer 2008;113:1097-106
  • NHS Choices. Effects of alcohol. Available from: Accessed 08 March 2011
  • Oliffe J. Embodied masculinity and androgen deprivation therapy. Sociology of Health and Illness 2006; 28(4): 410-432
  • Planas J, Morote J, Orsola A, Salvador C, Trilla E, Cecchini L et al. The relationship between daily calcium intake and bone mineral density in men with prostate cancer. British Journal of Urology. 2007; 99: 812-816
  • Segal RJ, Reid RD, Courneya KS et al. Resistance training in men receiving androgen deprivation for prostate cancer. J Clin.Oncol 2003; 21:1653-9
  • Smith MR, Egerdie B, Toriz NH et al. Denosumab in me receiving androgen-deprivation therapy for prostate cancer. N Eng J Med. 2009;361(8):745-755
  • Storey DJ, McLaren DB, Atkinson MA, et al. Clinically relevant fatigue in men with hormonesensitive prostate cancer on long-term androgen deprivation therapy. Annals of Oncology. 2012; 23:1542-1549
  • Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer. 2008;16:987-997
  • Viani GA, Bernardes da Silva LG, Stefano EJ. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy? Int J Radiat Oncol Biol Phys. 2012;83(4):e519-24
  • Yousaf O, Stefanopoulou E, Grunfeld EA et al. A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): trial protocol. BMC Cancer. 2012;12:230

About this publication  

This booklet is for men who are having hormone therapy for prostate cancer, their partners and families. It describes the different types of hormone therapy, how they work and what the treatment involves. It includes information on the possible side effects men may experience and suggests ways to help manage these.

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.

Download digital versions of this publication